NRXP NRX Pharmaceuticals

Watchlist

2.8500
-0.0900-3.06%

Close Feb 14 16:00 ET

3.0100
+0.1600+5.61%

Post 20:01 ET

48.21MMarket Cap-1.35P/E (TTM)

About NRX Pharmaceuticals Company

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Company Profile

SymbolNRXP

Company NameNRX Pharmaceuticals

Listing DateDec 1, 2017

Founded2017

CEODr. Jonathan C. Javitt,M.D.,M.P.H.

MarketNASDAQ

Fiscal Year Ends12-31

Address1201 Orange Street,Suite 600

CityWilmington

ProvinceDelaware

CountryUnited States of America

Zip Code19801

Phone1-484-254-6134

Websitehttp://www.nrxpharma.com

Company Executives

Name
Position
Salary

Dr. Jonathan C. Javitt,M.D.,M.P.H.
Chairman of the Board, Chief Scientist and Interim Chief Executive Officer
630.20K

Michael S. Abrams
Chief Financial Officer
--

Matthew Duffy
Chief Business Officer
--

Dr. Riccardo Panicucci, PhD
Chief Manufacturing and Technology Officer and Technical Operations Advisor
--

Mike Taylor
Director
--

Dr. Dennis McBride, PhD
Director
--

Chaim Hurvitz
Independent Director
52.50K

Patrick J. Flynn
Independent Director
67.50K

NRXP NRX Pharmaceuticals

About NRX Pharmaceuticals Company

Company Profile

Company Executives

Trending Stocks